CLIA Waivers Drive POCT ExpansionHow Will Growth Affect Labs?By Phil Kibak
POC devices and testing are a growing and lucrative segment of diagnostics. As manufacturers pursue CLIA waivers for their POC devices, testing outside the central laboratory is likely to spread even further.
Monitoring MPA in Solid-Organ Transplant RecipientsDoes TDM Reduce Organ Rejection and Adverse Events? By John R. Bell
Can monitoring of levels of mycophenolic acid in patients who receive transplanted solid organs lead to lower incidence of adverse events and rejections? A recent report from the Agency for Healthcare Research and Quality reviewed the current literature.
Apolipoprotein BIs it Time to Switch from LDL-C? By John H. Contois, PhD, and Joseph P. McConnell, PhD
With a recent consensus conference report from the American Diabetes Association and the American College of Cardiology highlighting its significance, the importance of apolipoprotein B in assessing cardiovascular disease risk is increasing.
U.S. Spends More for Less on Healthcare
News from the FDA
Download the entire issue
The New Standard in Diabetes: Estimated Average Glucose